Product Program year 2025 Source: CMS Open Payments

ImmunoCAP

Device Allergy/Immunology

Open in the dashboard

General payments

$1,645,196

31,155 payments

Research payments

$0

0 payments

Through program year 2025, $1,645,196 in general payments and $0 in research payments were reported against ImmunoCAP (Allergy/Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $191,225 4,086
2024 General $289,954 6,871
2023 General $306,551 6,048
2022 General $300,974 4,649
2021 General $197,508 4,608
2020 General $133,546 1,459
2019 General $225,438 3,434

Breakdown

Who paid General payments · program years 2019–2025
  1. Phadia US Inc. $1,645,196 31,155 payments
Top recipients General payments · program year 2025
  1. Sofia Szari Allergy & Immunology · Eglin Afb, FL $60,080 31% · 57 payments
  2. Geoffrey Carlson Allergy & Immunology · Travis Afb, CA $9,737 5% · 11 payments
  3. Joshua Sacha Allergy & Immunology · Travis Afb, CA $8,205 4% · 7 payments
  4. Crista Prates Nurse Practitioner, Adult Health · Absecon, NJ $7,013 4% · 9 payments
  5. David Schwartz Allergy · Bethesda, MD $6,864 4% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Allergy & Immunology $69,774 37% · 62 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $19,842 10% · 689 practitioners
  3. Family Medicine $17,197 9% · 560 practitioners
  4. Pediatrics $14,648 8% · 680 practitioners
  5. Allergy & Immunology Internal Medicine $9,856 5% · 8 practitioners

The top 5 of 83 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $69,061 36% · 451 recipients
  2. California $30,059 16% · 445 recipients
  3. Texas $14,075 7% · 458 recipients
  4. New Jersey $9,559 5% · 131 recipients
  5. Maryland $9,379 5% · 118 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

31,155 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record